2-(2-(3,5-dimethyl-1H-pyrazol-1-yl)-4-oxo-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-3-yl)-N-(5-methylisoxazol-3-yl)acetamide结构式
|
常用名 | 2-(2-(3,5-dimethyl-1H-pyrazol-1-yl)-4-oxo-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-3-yl)-N-(5-methylisoxazol-3-yl)acetamide | 英文名 | 2-(2-(3,5-dimethyl-1H-pyrazol-1-yl)-4-oxo-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-3-yl)-N-(5-methylisoxazol-3-yl)acetamide |
|---|---|---|---|---|
| CAS号 | 1007280-35-4 | 分子量 | 368.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C18H20N6O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 2-(2-(3,5-dimethyl-1H-pyrazol-1-yl)-4-oxo-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-3-yl)-N-(5-methylisoxazol-3-yl)acetamide |
|---|
| 分子式 | C18H20N6O3 |
|---|---|
| 分子量 | 368.4 |
| InChIKey | GJPXHFJBOGIDJY-UHFFFAOYSA-N |
| SMILES | Cc1cc(C)n(-c2nc3c(c(=O)n2CC(=O)Nc2cc(C)on2)CCC3)n1 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|